ZA911471B - The use of guanidine derivatives for the preparation of a pharmaceutical product having pny antagonistic activity - Google Patents
The use of guanidine derivatives for the preparation of a pharmaceutical product having pny antagonistic activityInfo
- Publication number
- ZA911471B ZA911471B ZA911471A ZA911471A ZA911471B ZA 911471 B ZA911471 B ZA 911471B ZA 911471 A ZA911471 A ZA 911471A ZA 911471 A ZA911471 A ZA 911471A ZA 911471 B ZA911471 B ZA 911471B
- Authority
- ZA
- South Africa
- Prior art keywords
- pny
- preparation
- antagonistic activity
- guanidine derivatives
- pharmaceutical product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP90106200A EP0448765B1 (de) | 1990-03-30 | 1990-03-30 | Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA911471B true ZA911471B (en) | 1991-11-27 |
Family
ID=8203843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA911471A ZA911471B (en) | 1990-03-30 | 1991-02-28 | The use of guanidine derivatives for the preparation of a pharmaceutical product having pny antagonistic activity |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0448765B1 (es) |
JP (1) | JPH0789939A (es) |
KR (1) | KR910016329A (es) |
AT (1) | ATE109979T1 (es) |
AU (1) | AU637882B2 (es) |
CA (1) | CA2037433A1 (es) |
DE (1) | DE59006842D1 (es) |
DK (1) | DK0448765T3 (es) |
ES (1) | ES2058651T3 (es) |
HU (1) | HU207945B (es) |
IE (1) | IE65252B1 (es) |
IL (1) | IL97424A (es) |
PT (1) | PT97138A (es) |
ZA (1) | ZA911471B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2126212A1 (en) * | 1991-12-19 | 1993-07-08 | Albert Tseng | A novel molecule which inhibits neuropeptide tyrosine biological function |
US5516653A (en) * | 1993-12-28 | 1996-05-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
US5545549A (en) * | 1994-02-03 | 1996-08-13 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof |
US5602024A (en) | 1994-12-02 | 1997-02-11 | Synaptic Pharmaceutical Corporation | DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
US5989920A (en) | 1994-12-02 | 1999-11-23 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5 |
WO1997020822A1 (en) * | 1995-12-01 | 1997-06-12 | Novartis Ag | Quinazolin-2,4-diazirines as npy receptor antagonist |
WO1997020823A2 (en) * | 1995-12-01 | 1997-06-12 | Novartis Ag | 2-amino quinazoline derivatives as npy receptor antagonists |
JP2001525793A (ja) * | 1996-05-14 | 2001-12-11 | ノボ ノルディスク アクティーゼルスカブ | ソマトスタチンの作動因子及び拮抗因子 |
DK0984778T3 (da) * | 1996-08-23 | 2002-09-16 | Agouron Pharma | Neuropeptid-Y-ligander |
FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
ZA979701B (en) * | 1996-10-31 | 1998-05-21 | Novo Nordisk As Novo Nordisk A | Constrained somatostatin agonists and antagonists.Constrained somatostatin agonists and antagonists. |
WO1998035944A1 (en) * | 1997-02-14 | 1998-08-20 | Bayer Corporation | Amides as npy5 receptor antagonists |
US6048900A (en) | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
AU6144098A (en) * | 1997-02-14 | 1998-09-08 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
US6713265B1 (en) | 1997-06-04 | 2004-03-30 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
AU744297B2 (en) | 1997-07-03 | 2002-02-21 | Neurogen Corporation | Certain diarylimidazole derivatives; a new class of NPY specific ligands |
ES2161594B1 (es) * | 1998-12-17 | 2003-04-01 | Servier Lab | Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
AU2935200A (en) | 1999-04-30 | 2000-11-17 | Pfizer Products Inc. | Compounds for the treatment of obesity |
US6518287B2 (en) | 2000-09-20 | 2003-02-11 | Schering Corporation | Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
AU2001291040A1 (en) | 2000-09-20 | 2002-04-02 | Schering Corporation | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
EP1318994B1 (en) | 2000-09-20 | 2008-02-27 | Schering Corporation | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
CA2422729A1 (en) | 2000-09-20 | 2002-06-06 | Schering Corporation | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3579000D1 (de) * | 1985-04-02 | 1990-09-06 | Heumann Pharma Gmbh & Co | Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. |
DE3631334A1 (de) * | 1986-09-15 | 1988-03-17 | Heumann Pharma Gmbh & Co | Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
-
1990
- 1990-03-30 ES ES90106200T patent/ES2058651T3/es not_active Expired - Lifetime
- 1990-03-30 AT AT90106200T patent/ATE109979T1/de active
- 1990-03-30 DK DK90106200.0T patent/DK0448765T3/da active
- 1990-03-30 EP EP90106200A patent/EP0448765B1/de not_active Expired - Lifetime
- 1990-03-30 DE DE59006842T patent/DE59006842D1/de not_active Expired - Fee Related
-
1991
- 1991-02-28 ZA ZA911471A patent/ZA911471B/xx unknown
- 1991-03-01 CA CA002037433A patent/CA2037433A1/en not_active Abandoned
- 1991-03-04 AU AU72068/91A patent/AU637882B2/en not_active Ceased
- 1991-03-04 IL IL9742491A patent/IL97424A/en not_active IP Right Cessation
- 1991-03-25 HU HU91979A patent/HU207945B/hu not_active IP Right Cessation
- 1991-03-25 PT PT97138A patent/PT97138A/pt not_active Application Discontinuation
- 1991-03-26 JP JP3061914A patent/JPH0789939A/ja active Pending
- 1991-03-26 IE IE99591A patent/IE65252B1/en not_active IP Right Cessation
- 1991-03-27 KR KR1019910004812A patent/KR910016329A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE59006842D1 (de) | 1994-09-22 |
HU910979D0 (en) | 1991-10-28 |
DK0448765T3 (da) | 1994-09-19 |
EP0448765B1 (de) | 1994-08-17 |
KR910016329A (ko) | 1991-11-05 |
JPH0789939A (ja) | 1995-04-04 |
IE65252B1 (en) | 1995-10-18 |
HU207945B (en) | 1993-07-28 |
AU637882B2 (en) | 1993-06-10 |
PT97138A (pt) | 1991-11-29 |
IE910995A1 (en) | 1991-10-09 |
AU7206891A (en) | 1991-10-03 |
HUT57044A (en) | 1991-11-28 |
ES2058651T3 (es) | 1994-11-01 |
ATE109979T1 (de) | 1994-09-15 |
EP0448765A1 (de) | 1991-10-02 |
CA2037433A1 (en) | 1991-10-01 |
IL97424A0 (en) | 1992-06-21 |
IL97424A (en) | 1995-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA911471B (en) | The use of guanidine derivatives for the preparation of a pharmaceutical product having pny antagonistic activity | |
CA2122612A1 (en) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
AU2506388A (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
DE69420412T2 (de) | Therapeutisches inhalationspräparat | |
CA2041579A1 (en) | Dosage form | |
ATE163849T1 (de) | Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure | |
CS189391A3 (en) | Dialkoxypiridylbenzimidazole derivatives, process of their preparation and their pharmaceutical use | |
HU912266D0 (en) | Process for the production of solid medical preparations with controlled portioning of the active agents for oral use | |
HU9300636D0 (en) | Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine | |
AU1968992A (en) | Preparation of fatty acid medicaments | |
RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
GR3006091T3 (es) | ||
HU913137D0 (en) | 2-amino-4-carboxamido-pirimidine derivatives, their production and medical use | |
HU911756D0 (en) | Process for the production of medical preparations containing magnesium-pyridoxal-5'-phosphate-glutaminate, for the preventing of arterial diseases | |
ATE162076T1 (de) | Verwendung von nadh und nadph zur herstellung eines arzneimittels zur behandlung von morbus alzheimer | |
NZ332105A (en) | Medicaments including human growth hormone for the treatment of type II diabetes and metabolic syndrome | |
ATE122883T1 (de) | Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze. | |
EP0732401A3 (en) | Megacaryocyte stimulating factor (meg-CSF) | |
AU7076494A (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
NO307126B1 (no) | Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom | |
EP0651741A1 (en) | DERIVATIVES OF N? G -MONOMETHYL-L-ARGININE HYDROCHLORIDE AND THEIR USE IN THE TREATMENT OF SEPTIC SHOCK. | |
NO890997D0 (no) | Applikator for hudrensemiddel, hudpleiemiddel og medisinsk salve. | |
EP0418065A3 (en) | Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same | |
ATE137968T1 (de) | Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen | |
UA13401C2 (uk) | Ветеринарний препарат для профілактики та лікування хвороб вірусної та бактеріальної природи |